BRIEF-Anthera Pharmaceuticals Announces Positive Outcome In The Phase 3 Result Clinical Study Of Sollpura
Dec 11 (Reuters) - Anthera Pharmaceuticals Inc:
* ANTHERA PHARMACEUTICALS ANNOUNCES POSITIVE OUTCOME OF INTERIM FUTILITY ANALYSIS IN THE PHASE 3 RESULT CLINICAL STUDY OF SOLLPURA
* BASED ON INTERIM FUTILITY ANALYSIS, RESULT STUDY WILL PROCEED, AS PLANNED, WITH TOPLINE DATA EXPECTED IN Q1 2018 Source text for Eikon: Further company coverage: